DANAHER CORPORATION shareholders Q4 2020

DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.

DANAHER CORPORATION shareholders Q4 2020
Name	Shares	Value	Weighting ↓
PARNASSUS INVESTMENTS, LLC	4,751,952	$1,055,599,000	2.86%
TANDEM CAPITAL MANAGEMENT CORP /ADV	16,886	$3,751,000	2.82%
Notis-McConarty Edward	31,071	$6,902,000	2.81%
JGP Global Gestao de Recursos Ltda.	3,354	$745,000	2.80%
NORTHSTAR ASSET MANAGEMENT Co LLC	44,257	$9,831,000	2.79%
MARSHALL & SULLIVAN INC /WA/	6,245	$28,112,000	2.78%
Stewart Asset Management, LLC	20,450	$4,543,000	2.76%
Vancity Investment Management Ltd	62,221	$13,822,000	2.76%
KING LUTHER CAPITAL MANAGEMENT CORP	2,189,990	$486,484,000	2.74%
Findlay Park Partners LLP	1,763,050	$391,644,000	2.72%
Parkman Healthcare Partners LLC	47,687	$10,593,000	2.71%
D1 Capital Partners L.P.	2,582,346	$573,642,000	2.71%
NORTH AMERICAN MANAGEMENT CORP	85,902	$19,082,353,000	2.70%
McCollum Christoferson Group LLC	46,910	$10,421,000	2.66%
Sky Investment Group LLC	47,060	$10,454,000	2.66%
Maple Capital Management, Inc.	77,185	$17,146,000	2.64%
HOWLAND CAPITAL MANAGEMENT LLC	202,490	$44,981,000	2.64%
Dash Acquisitions Inc.	16,737	$3,718,000	2.60%
EUBEL BRADY & SUTTMAN ASSET MANAGEMENT INC	48,259	$10,720,000	2.57%
KAVAR CAPITAL PARTNERS GROUP, LLC	40,152	$8,919,000	2.56%

About DANAHER CORPORATION

Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.

Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.

Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.

In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

External links

This page lists DANAHER CORPORATION's shareholders in Q4 2020. To view DANAHER CORPORATION's shareholder history, click here.